rosuvastatin 20 mg daily for 4 weeks	atorvastatin 40 mg daily 	Erythrocyte sedimentation rate (ESR)	9836	9943	There was no statistically significant difference between the levels of ESR in the patients of both groups.
rosuvastatin 20 mg daily for 4 weeks	atorvastatin 40 mg daily 	CRP levels	982	1167	However, there was significant difference between the levels of CRP in patients of the rosuvastatin group as compared to the atorvastatin group (19.91 ± 6.32 vs 23.07 ± 7.47, P < 0.05).
atorvastatin 40 mg daily, rosuvastatin 20 mg daily for 4 weeks	baseline	CRP levels	779	1169	CRP levels significantly decreased from beginning to the end of 4 weeks in both atorvastatin and rosuvastatin groups (from 35.48 to 23.07 mg/l and from 35.88 to 19.91 mg/l respectively, both P < 0.001). However, there was significant difference between the levels of CRP in patients of the rosuvastatin group as compared to the atorvastatin group (19.91 ± 6.32 vs 23.07 ± 7.47, P < 0.05). I
rosuvastatin 20 mg daily for 4 weeks	atorvastatin 40 mg daily 	Adverse effect	12086	12286	All adverse effects were mild in severity and did not need alteration in treatment. There was no statistically significant difference between the two groups on account of incidence of adverse effects.
atorvastatin 40 mg daily, rosuvastatin 20 mg daily for 4 weeks	baseline	CRP levels	779	981	CRP levels significantly decreased from beginning to the end of 4 weeks in both atorvastatin and rosuvastatin groups (from 35.48 to 23.07 mg/l and from 35.88 to 19.91 mg/l respectively, both P < 0.001).
rosuvastatin 20 mg daily for 4 weeks	atorvastatin 40 mg daily 	CRP levels	779	1167	CRP levels significantly decreased from beginning to the end of 4 weeks in both atorvastatin and rosuvastatin groups (from 35.48 to 23.07 mg/l and from 35.88 to 19.91 mg/l respectively, both P < 0.001). However, there was significant difference between the levels of CRP in patients of the rosuvastatin group as compared to the atorvastatin group (19.91 ± 6.32 vs 23.07 ± 7.47, P < 0.05).
rosuvastatin 20 mg daily for 4 weeks	atorvastatin 40 mg daily 	lipid profile	11057	11185	There was no statistically significant difference between the changes in lipid profile in both groups. All P values were > 0.05.
